Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 May 12;16(5):e0251605. doi: 10.1371/journal.pone.0251605

COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence

Md Saiful Islam 1,2,¤,*, Abu-Hena Mostofa Kamal 3,4, Alamgir Kabir 2,5, Dorothy L Southern 6, Sazzad Hossain Khan 1, S M Murshid Hasan 7, Tonmoy Sarkar 1, Shayla Sharmin 8, Shiuli Das 1, Tuhin Roy 9, Md Golam Dostogir Harun 1, Abrar Ahmad Chughtai 2, Nusrat Homaira 10, Holly Seale 2
Editor: Luigi Lavorgna11
PMCID: PMC8115834  PMID: 33979412

Abstract

Introduction

Rumors and conspiracy theories, can contribute to vaccine hesitancy. Monitoring online data related to COVID-19 vaccine candidates can track vaccine misinformation in real-time and assist in negating its impact. This study aimed to examine COVID-19 vaccine rumors and conspiracy theories circulating on online platforms, understand their context, and then review interventions to manage this misinformation and increase vaccine acceptance.

Method

In June 2020, a multi-disciplinary team was formed to review and collect online rumors and conspiracy theories between 31 December 2019–30 November 2020. Sources included Google, Google Fact Check, Facebook, YouTube, Twitter, fact-checking agency websites, and television and newspaper websites. Quantitative data were extracted, entered in an Excel spreadsheet, and analyzed descriptively using the statistical package R version 4.0.3. We conducted a content analysis of the qualitative information from news articles, online reports and blogs and compared with findings from quantitative data. Based on the fact-checking agency ratings, information was categorized as true, false, misleading, or exaggerated.

Results

We identified 637 COVID-19 vaccine-related items: 91% were rumors and 9% were conspiracy theories from 52 countries. Of the 578 rumors, 36% were related to vaccine development, availability, and access, 20% related to morbidity and mortality, 8% to safety, efficacy, and acceptance, and the rest were other categories. Of the 637 items, 5% (30/) were true, 83% (528/637) were false, 10% (66/637) were misleading, and 2% (13/637) were exaggerated.

Conclusions

Rumors and conspiracy theories may lead to mistrust contributing to vaccine hesitancy. Tracking COVID-19 vaccine misinformation in real-time and engaging with social media to disseminate correct information could help safeguard the public against misinformation.

Introduction

Rumors and conspiracy theories, have been identified as precipitators for vaccine hesitancy [1]. People may decline immunizations due to false claims that vaccines contain infertility agents or can spread an infectious pathogen such as human immunodeficiency virus (HIV) [2, 3]. Historically, negative claims about vaccine effectiveness have affected vaccine uptake. A boycott of the polio vaccine due to rumors that the vaccine caused infertility led to increased polio cases in Nigeria, Pakistan, and Afghanistan [2, 4]. Rumors often challenge the health policies and interventions of government and non-government officials and international health agencies such as the World Health Organization (WHO) [5]. Whether a person believes the misinformation or not is dependent on the individual’s level of health literacy and their risk perceptions. However, continuous exposure to social media and online anti-vaccine movement may influence people to share and communicate vaccine misinformation and conspiracy theories [68].

Social media platforms have become a common source for health information. During a pandemic, people may use social media to improve their knowledge about the disease, transmission, and prevention mechanisms [9, 10]. Health information circulating on online platforms are often amplified by rumors and conspiracy theories that are not always based on scientific evidence [11]. Health information-seeking behavior on online platforms puts users at risk of being exposed to misinformation that could potentially threaten public health [12]. A 2020 study conducted by Stecula and colleagues found that people who were exposed to vaccine-related information on social media were more likely to be misinformed and become vaccine-hesitant [13]. A separate study of 2000 adults in the United Kingdom (UK) conducted by the Royal Society for Public Health, found that two-fifths of the participants encountered negative messages about vaccination on social media platforms [14]. People often share concerns, mistrust and rumors about vaccines on social media before they are detected through a traditional surveillance system, such as event-based surveillance [15]. Therefore, monitoring this media data has been identified as one of the best methods for tracking misinformation in real-time and as a possible way to dispel misinformation and optimize vaccine acceptance.

Given that in early 2021 there are at least four vaccine candidates that have been approved for emergency use against COVID-19 with more options planned for approval, it is critical that efforts are made to start tracking the misinformation being spread [16]. Lack of confidence in COVID-19 vaccine candidates may lead some people to delay or refuse the new vaccine, potentially disrupting national and international control efforts [17].

Culturally compelling and context-appropriate information, supported by credible sources, are required to prevent vaccine misinformation [18]. This study aimed to examine COVID-19 vaccine rumors and conspiracy theories circulating on online platforms, understand their context, and then review interventions to manage this misinformation and increase vaccine acceptance.

Materials and methods

Study design

This was a mixed-method study where we utilized both quantitative and qualitative approaches. In June 2020, a team of social scientists trained in infodemic management and epidemiologists was formed to review and collect COVID-19 vaccine(s) information circulating globally on the online platforms. The team collected the data between 31 December 2019, the day the COVID-19 pandemic was first notified in China, to 30 November 2020.

Study definitions

We defined rumors as any unverified claims related to COVID-19 vaccine(s) or the process of immunization/vaccination circulating on the online platforms that could be classified as true, false, misleading or exaggerated after verification by the fact-checking agencies [19]. As adapted from Wardle et al. (2021), misinformation was defined as inaccurate or false information shared by someone unwittingly and without any intention to cause harm [20]. We defined conspiracy theories as any claims by an individual or group of people to reach malicious goals [21].

Data collection

A wide range of sources including Google, Google Fact Check, Facebook, YouTube, Twitter, websites of fact-check agencies, websites of television and newspaper were reviewed. We searched reports in English using the following search terms “2019-nCoV vaccine” or “COVID-19 vaccine” or “2019 novel coronavirus vaccine” and “rumor” or “misinformation” “false information” “fake news” or “conspiracy theories”. For each combination of terms searched on Google, we limited our screening to the first 10 pages for evaluation. The fact-check agencies reported vaccine rumors either in English or in local languages and some also published the weblinks of vaccine rumors and conspiracy theories along with screen shots of social media posts on the websites. We visited the websites, reviewed the contents, and documented all the information they reported related to vaccine rumors into our database.

Data extraction and consistency

Once the vaccine-related items were identified, the team made a list of weblinks. The links were then distributed among nine researchers who had prior experience of extracting data from web-based sources. Each team member visited the allocated weblinks that took the team member to the original content, reviewed the full content of each claim multiple times, and extracted the data into a spreadsheet using a checklist used in a previous infodemiology study. We collected data on the title, country, date, language, social media platform(s) type of information and their factual rating. To measure the magnitude of the spread of each of the news articles, social media narratives and online reports and/or blogs, we collected the number of available likes, shares, emojis and retweets. Once the data were extracted, the team swapped their weblinks with another member to check for data entry error and consistency. When discrepancies in data entry were found, the lead author met with the data entry team, reviewed the report, and resolved any discrepancies. Once all the data were entered in the spreadsheet, the data were then sorted to check for duplication. Duplicate weblinks, and contents that could not be translated into English, were excluded from the analysis. Finally, we used the Google Trends tool to retrieve data on the internet users’ searches related to COVID-19 vaccine(s). We retrieved the data for the study period using the search queries, “COVID-19 vaccine” in English.

Data analysis

We descriptively analyzed the quantitative data using the open-source statistical package R version 4.0.3 (R Project for Statistical Computing, Vienna, Austria). Stacked bar charts were used to depict the distribution of different news articles, social media narratives, online reports and or blogs by date and country. We also constructed a line chart to show online users search activity related to COVID-19 vaccine on Google. We constructed a global map to describe the geographical distribution of the total count of the rumors and conspiracy theories reported. We also constructed a Venn diagram to show the number of rumors or conspiracy theories shared among different social media platforms. For news articles, online reports, blogs, and fact-check agency reports we conducted content analysis to compare the data collected. The data were then categorized under predefined themes: rumor or conspiracy theory and emergent sub-themes identified by the typology of claims circulating on the online platform, including COVID-19 vaccine development, availability and access, vaccine related morbidity and mortality, political and economic motives, safety, efficacy and acceptance, COVID-19 susceptibility due to exposure to other vaccines, vaccine reagents, mandatory vaccines and ethics, vaccine alternatives and necessity, conspiracy theories and miscellaneous (Table 1). The lead author shared the analysis among all co-authors for review and consensus. Using the fact-check agency ratings, the team also categorized the rumors and conspiracy theories as ’true ’, ’false’, ’misleading’ and ’exaggerated’ [22].

Table 1. Operational definitions of study sub-themes, 31 December 2019–30 November 2020.

Sub-themes Operational definitions
Vaccine development, availability, and access Reports of rumors and conspiracy theories related to the policy, progress, and challenges of COVID-19 vaccine trial, phases of trials, trial participants and development were included under this category. This also includes past and ongoing availability of COVID-19 vaccines, it’s delivery and public access to them [34].
Safety, efficacy, and acceptance Claims related to the safety and efficacy of COVID-19 vaccine and its acceptance
Political and economic motives The political and economic interest of COVID-10 vaccines and its development [34].
Conspiracy theory Claims and discussion of various theories related to the COVID-19 vaccine and its malicious goals
Mandatory vaccine and ethics Claims related to concerns about mandatory vaccine and ethics.
Vaccine reagents Claims pertaining to concerns about what materials have been used in vaccine
Morbidity and mortality Posts containing claims about morbidity and mortality due to participation in vaccine trials or receiving vaccine in future
Vaccine alternatives Content related to the alternative options to vaccine
Susceptibility due to other vaccine exposure State or claims related to exposures to other vaccine and vulnerability to COVID-19
Miscellaneous Statements, claims and discussion that did not fit to the above sub-themes

Ethics

Only publicly available information was collected. The study protocol was reviewed and approved by the institutional review board of the University of New South Wales ethical review committee (HC200739), Sydney, Australia.

Results

The surveillance identified 637 rumors and conspiracy theories related to COVID-19 vaccine in 24 languages from 52 countries (Fig 1). Of the total, 91% (578/637) were classified as rumors and 9% (59/637) as conspiracy theories. These items included news articles, social media narratives, online reports and/or blogs that approximately 103.3 million people had liked, shared, reacted to with an emoji, or retweeted on social media. Of all the items, 15% (94/637) were reported in the United States, 13% (82/637) in India, and 12% (77/637) in Brazil. The African continent reported the least (Fig 2). Facebook was the most prevalent (61%) media, followed by Twitter (28.6%) (Fig 3).

Fig 1. Global distribution of rumors and conspiracy theories related to COVID-19 vaccine, 31 December 2019–30 November 2020.

Fig 1

Fig 2. Rumor and conspiracy theories related to COVID-19 vaccine by country, 31 December 2019–30 November 2020.

Fig 2

Fig 3. Rumors and conspiracy theories related to COVID-19 vaccine circulating on different social media platforms, 31 December 2019–30 November 2020.

Fig 3

The surveillance identified three waves of COVID-19 vaccine rumors and conspiracy theories between 10 January to 30 November 2020. The first wave was between February and May 2020, the second wave between June and September 2020, and the third wave between 16 October and 20 November 2020 (Fig 4). The second wave had the most rumors and conspiracy theories when compared with the first and the third wave. During the initial months of COVID-19, most of the COVID-19 vaccine claims were related to pre-pandemic vaccine and conspiracy theories. More recent claims were related to efficacy and effectiveness of the vaccine, morbidity, and mortality due to participation in the vaccine trial. The three waves of rumors and conspiracy theories we detected were consistent with the three waves of Google Search on COVID-19 vaccine (Fig 3).

Fig 4. Spread of misinformation and internet users search interest related to COVID-19 vaccines, 31 December 2019–30 November 2020.

Fig 4

*Google Trends: Numbers represent search interest relative to the highest point on the chart for the given region and time. A value of 100 is the peak popularity for the term. A value of 50 means that the term is half as popular. A score of 0 means there was not enough data for this term.

Rumors

Of the 578 items classified as rumors, we further classified them according to sub-themes Table 2.

Table 2. Rumors and conspiracy theories related to COVID-19 vaccine circulating online, 31 December 2019–30 November 2020.

Categories Claims
Vaccine development, availability, and access Indonesia is the only country that has been the guinea pig of the COVID-19. Vaccine from China, even though China does not want to test the vaccine on its people.
COVID-19 vaccine was tested in Indonesia because Chinese laboratories lacked monkeys.
Putin’s daughter was among the volunteers for COVID 19 vaccine trials.
Dr Anthony Fauci, the nation’s leading infectious disease expert, has made a statement" the COVID-19 vaccine should be rushed through development without proper clinical trials".
Oxford vaccine against COVID-19 will be ready in September.
COVID-19: Vaccine manufacturers are granted indemnification.
Safety, efficacy, and acceptance COVID-19 vaccine will cause infertility.
COVID-19 vaccine may not be effective and has serious side effects.
Bill Gates explains that the COVID vaccine will use experimental technology and permanently alter your DNA.
WHO admits COVID vaccines will not work.
Coronavirus vaccine is ready, able to cure a patient within 3 hours.
The COVID-19 vaccine "contains DNA modifiers and multipliers.
Anthony Fauci remarks that vaccines are toxic and can make you worse.
160 doctors disapprove of the COVID vaccine because it will change our DNA.
Every fourth American is against taking COVID-19 Vaccine.
One in six people will refuse a coronavirus vaccine.
Susceptibility due to influenza vaccine Flu vaccines make people more vulnerable to infections.
People vaccinated for seasonal influenza face higher chances of catching SARS-COV-2, which causes COVID-19.
Flu vaccines increase the odds of getting COVID-19.
Flu vaccine makes kids more vulnerable to coronaviruses.
Flu Vaccine Kills COVID Patients.
Morbidity and mortality Two children die from COVID-19 Vaccine in Guinea.
WHAT??? French Doctors Kill Two in Deadly Vaccine Trials.
COVID-19 patients died in Guinea after taking a trial vaccine.
Microsoft founder-turned-philanthropist Bill Gates "admits" in an interview that a COVID-19 vaccine could kill or injure up to 700,000 people.
The COVID-19 vaccine will kill 50 million Americans.
American Vaccine against COVID-19 in Ukraine killed 30 per cent of patients.
All participants in a COVID-19 vaccine trials had side effects.
Russian President Vladimir Putin’s daughter died on August 15th, 2020, after taking a dose of a new COVID-19 vaccine.
Seven children in Senegal died after being given a vaccine for coronavirus.
My friend just buried 3 children after getting the Vaccine from China.
One of the first volunteers of a COVID-19 vaccine trial in the UK, died.
Vaccines to prevent COVID-19 will modify genes and cause male infertility.
Conspiracy theories Certificate of Identification of Vaccination with Artificial Intelligence.
With the introduction of the COVID-19 vaccine, microchips (nano-chips) will also be introduced into the human body, then 5G networks will enter the business, through which the world elite will send various signals to the chips, thereby controlling humanity.
The COVID-19 virus is an excuse to inject us with a vaccine that will synchronize us to a digital identity that will be issued in the Civil Registry.
Bill Gates, the founder of harmful vaccination campaigns in developing countries, now plans to use COVID-19 vaccines to surveil the population.
The BBC published a travel piece stating that there will be microchips in the future vaccines funded by the Bill Gates so they can track who has been vaccinated for coronavirus.
COVID-19 is a plan to kill older adults with contaminated vaccines.
Political and economic motives Pharmaceutical companies withheld positive news about its coronavirus vaccine until after the election.
After vaccination against COVID-19, the population of the planet will decrease to 1 billion.
Joe Biden and running mate Kamala Harris are spreading anti-vaccine conspiracy theories" about a COVID-19 vaccine.
Bill Gates vaccine new world order.
Canada will introduce a “World Debt Reset Program,” which will set personal debts to zero if a person agrees to get vaccinated for COVID-19 and COVID-21.
Vaccine alternatives Paradigm Shift: US government relies on alternative therapies instead of vaccinations!
COVID-19 will leave the country on its own: health minister.
COVID-19 vaccines are no different from the flu vaccine.
With the survival rate of COVID-19 close to 100% without a vaccine, what exactly will the purpose of the new vaccine be?
One cube sugar with polio vaccine will be effective for corona treatment.
The anti-tuberculosis Bacillus Calmette-Gurin (BCG) vaccine protects people against coronavirus infection.
Vaccine reagents Coronavirus vaccine is made from cells of aborted fetuses.
The vaccine being tested in Brazil is produced with cells from aborted fetuses.
The Covid-19 Vaccine contains toxic ingredients.
Humans will be injected with monkey and pig genes with the Covid-19 Vaccine.
Mandatory vaccine and ethics New Zealand Government can force citizens to be vaccinated.
Vaccinations violate human rights under the principles of the Nuremberg Code.
Doria has banned hydroxychloroquine against covid-19 and wants to force people to get an experimental vaccine.
Biden COVID-19 task force member recommends withholding rent, food stamps from those who refuse the vaccine.

Vaccine trials, development, and access

Of the rumors identified, 39% (227/578) were related to COVID-19 vaccine trials, development, delivery, and access. Of these, 76% (173/227) were identified as false/misinformation. Most of these claims described either the start or end of a vaccine trial, the timeline for the roll out of mass vaccination, countries and companies involved in the development process, photos of high-profile people participating in a vaccine trial, and people’s access to the vaccine. One of the claims was that Chinese laboratories lacked monkeys, and therefore, the Chinese developed a vaccine that was trialed in Indonesia. Another Facebook post warned people not to be part of the vaccine trial in India. A rumor circulated in Bangladesh that China wanted to use Bangladesh citizens as guinea pigs for a vaccine trial. Another dominant rumor was that crucial phases of the clinical trials were skipped as the pharmaceutical companies would not compensate participants for adverse side effects during the trial. Another commonly circulating rumor was that a Russian vaccine company omitted Phase 3 clinical trials for a COVID-19 vaccine. This claim provoked a lot of concern and criticism from the scientific community that the vaccine was not tested for effectiveness or safety in many humans which might lead to global concern and vaccine hesitancy.

Morbidity and mortality related to vaccine

The second most common subtheme tracked 22% (125/578) was related to morbidity and mortality due to receiving the COVID-19 vaccine. The most common circulating rumor was that the COVID-19 vaccine would be a messenger Ribonucleic acid (mRNA) vaccine that could alter people’s Deoxyribonucleic acid (DNA), subsequently turning them into a genetically modified human being. Other posts postulated that 160 doctors disapproved of the COVID-19 vaccine as it could change human DNA or that it could modify genes, cause cancers, and infertility. Other claims linked the vaccine to crippled children in Africa and to clinical trial participants who had become ill or had severe allergic reactions after being vaccinated. Some claims stressed that the COVID-19 vaccine was aimed at reducing the world’s population, while others raised concerns about vaccine-derived COVID-19 in Russia.

Regarding mortality, some of the claims were related to the estimated deaths due to COVID-19 vaccine and participation in vaccine trials. One of the widely circulated false claims was that the daughter of the Russian president had died after receiving the second dose of COVID-19 vaccine. We also identified other misinformation related to children and soldiers dying after receiving the vaccine in multiple countries; it was reported on Facebook that seven children died after receiving the COVID-19 vaccine in Senegal. Lastly, it was falsely reported that Bill Gates had said that 700,000 people would be injured or die from the COVID-19 vaccine.

Influenza vaccine increase susceptibility to COVID-19 infection

Of the rumors identified, 4% (23/578) claimed people who were vaccinated for seasonal influenza were at higher risk of COVID-19 infection. Some of the claims argued that largest number of COVID-19 deaths occurred in countries with a higher uptake rate of influenza vaccine among the elderly. It was also claimed that people had been injected with the virus during the administration of influenza vaccine during mass campaigns. Referring to an epidemiological study [23], one claim highlighted that persons with COVID-19 infection who received an influenza vaccine in 2019 were more likely to be hospitalized, and once hospitalized, were more likely to die. Although this finding was not statistically significant after adjusting for confounders, some people highlighted these partial results that then became viral on multiple social media platforms. Another false claim was that the risk of infection of COVID-19 increased by 36% due to the influenza vaccine [24].

Vaccine safety, efficacy, and acceptance

Nine percent (50/578) of rumors were related to safety, efficacy, and acceptance of COVID-19 vaccine. For example, the natural survival rate from COVID-19 without the vaccine would be greater than the effectiveness of the vaccine. Some claims mentioned that COVID-19 vaccine is a ‘total hoax’. A few argued that SARS-COV-2 is a rapidly changing virus, and therefore, the vaccine may not be effective against the future strains of the virus. One claim mentioned that the WHO had admitted the COVID-19 vaccine would not work; another claimed the vaccine would have 80% adverse effects. Regarding acceptance, it was claimed that one in every four Americans was against the vaccine, and that the former US President had urged Africans not to receive vaccines from the USA or UK.

Vaccine reagents

Six percent (32/578) of rumors were related to COVID-19 vaccine reagents. Of these, 11claimed that the COVID-19 vaccines were being produced with cells from aborted fetuses with one citing the presence of aborted fetus cells in a vaccine producing laboratory in Brazil. Other claimed that the vaccine contained genes from monkeys and pigs. There were also reports that the vaccine contained aluminum that could cause Alzheimer’s disease.

Vaccine alternatives and necessity

Four percent (24/578) of rumors were related to vaccine alternatives and necessity. Many posts claimed that the virus would go away naturally, with no need for a vaccine. One of the posts claimed that the US Government was relying on hydroxychloroquine as an alternative therapy to the vaccine. There were also claims about natural immunity being the best defense against COVID-19, and that eating beef was the best vaccine against COVID-19. Other posts also claimed that the pneumococcal vaccine, Haemophilus influenza type B (Hib) vaccine, the Tuberculosis vaccine (BCG), or one cube of sugar containing the polio vaccine could protect against coronavirus infection.

Political and economic motives

Two percent (14/578) of rumors were linked to political or economic interest related to the COVID-19 vaccine. The most popular rumor related to economic motives postulated that the vaccine was invented before the COVID-19 pandemic to advance vaccine sales. There were reports that big pharmaceutical companies were negotiating with social media companies, national and international health agencies, newspapers, and television channels to raise vaccine demand among the public for their own financial gain through increased vaccine sales. Other claims were that COVID-19 vaccine development was used as a weapon during the 2020 election campaign in USA and big pharmaceutical companies withheld the positive news about vaccine development until the election results. Another rumor claimed that a free COVID-19 vaccine would be available to those voting for the ruling party in India.

Conspiracy theories

Of the 59 items classified as conspiracy theories, 97% (57/59) were false. The most popular conspiracy theory circulating via the online platforms was that the COVID-19 vaccine could monitor the human population and take over the world. One theory proposed was the COVID-19 vaccine would contain a microchip through which biometric data could be collected, and large businesses could send signals to the chips using 5G networks, thereby controlling humanity. Another conspiracy theory was that vaccination against COVID-19 was intended to genetically modify humans.

Discussion

This study identified numerous rumors and conspiracy theories that have the potential to negatively impact the confidence of populations towards the COVID-19 vaccine. In the absence of fact-based information, the circulation of these rumors on multiple social media platforms has the potential to be misinterpreted as credible information. Herd immunity against misinformation and conspiracy theories is required to ensure herd immunity against SARS-CoV-2; the virus causing COVID-19 [5]. It is estimated that the vaccine coverage needs to be approximately 55% to 88% in order to achieve herd immunity against SARS-CoV-2 [25]. However, variations across countries in terms of ‘willingness to receive the COVID-19 vaccine’ have already been documented [26].

While acknowledging that numerous contextual, social and vaccine related factors can influence vaccine acceptance, including perceptions of the likelihood of getting the disease and risk perceptions towards the vaccine [27], the unsubstantiated claims of morbidity and mortality related to COVID-19 vaccine circulating online may affect COVID-19 vaccine confidence [13, 28]. A national survey conducted among US adults in September 2020 on willingness to get COVID-19 vaccine found a 21% decline when compared with another national survey conducted in May 2020 among similar groups. This decline could be attributable to the exposure to COVID-19 vaccine misinformation on social media [2932]. In another study, conducted among parents in Australia, 24.3% (458/2018) participants were unsure or not willing to accept a COVID-19 vaccine. Of these, 89% were concerned about vaccine efficacy and safety, and 27% did not believe a COVID-19 vaccine was necessary [33].

For a novel vaccine such as COVID-19 to be successful, the safety and efficacy of the vaccine and its wide acceptance needs to be ensured. As COVID-19 vaccine trials are advancing, so are numerous claims about COVID-19 vaccine safety and efficacy, some of which are false and misleading. While some national and international health agencies and fact-check organizations debunked these claims, the time gap between tracking and debunking misinformation, and its limited reach, may have left some populations vulnerable to vaccine hesitancy [34].

Prior studies showed political beliefs and attitudes towards vaccines are well connected [35, 36]. Our findings that the COVID-19 vaccine has been used for economic and political interest is consistent with studies focused on vaccine rumors conducted prior to 2020 [37]. Rumors that focus on vaccine development delays, or that vaccines will only be freely available to ruling government supporters, may create distrust between government stakeholders and the public. This could ultimately affect any vaccine-related policy implementation. Rumors about the use of vaccination campaigns for political purposes are not new, and such rumors have previously affected vaccination campaigns in some countries, such as Pakistan [38]. During a public health emergency, when there is considerable scientific uncertainty, and political leaders act as frontline crises managers, it often becomes challenging to ensure evidenced-based recommendation over political interest [35]. For example, the statement, “Whether the vaccine comes or not, coronavirus will leave the country” made by a health minister is likely to confuse the public about the necessity of the vaccine [39]. It thus may affect vaccine acceptancy.

The claim that vaccine against COVID-19 had already been invented may lead some to come to the conclusion that this pandemic was being used in an attempt to further vaccine sales [40, 41]. Such misinformation may lead to mistrust on pharmaceutical companies, healthcare agencies and emergency responders and impact overall vaccine acceptancy [42]. Misinformation such as emergence of vaccine-derived SARS-COV-2 virus, or that influenza vaccine can increase the risk of COVID-19 infection, has the potential not only to negatively affect COVID-19 vaccine acceptance, but may also have detrimental impact on confidence in the influenza vaccine, as was identified in Australia [43]. This claim was based on the finding of a study conducted by Wolf (2020), who noted that people who received the influenza vaccine were 1.36 times more likely to develop respiratory disease caused by a seasonal coronavirus [24].

The rumors that COVID-19 vaccine contains cells from aborted fetus or genes from pigs raised religious concern among the Muslims and Jewish communities. In response to such claims, several ministries in Indonesia were said to slow down the rollout of COVID-19 vaccines unless they received a halal certification to ensure the vaccine is permissible under Islamic law [44]. A similar rumor that the measles and rubella vaccines contained ingredients from pigs, and therefore was not permissible in Islam, resulted in a sharp decline in vaccine acceptancy in Indonesia [45]. The commentary around the use of aborted fetus cells in COVID-19 vaccine may also affect vaccine acceptance among Christians and Buddhists [46]. To combat these rumors, communication materials must be co-designed with the communities of interest, including religious and community leaders, relevant community groups and members. The traditional and religious community leaders can promote immunization by providing practical information, such as vaccination session locations and schedules, during community announcements and after religious services.

The Google Trend analysis showed that there was a high demand for COVID-19 vaccine related information on online platform. The waves of rumors we detected corresponded with the waves of online users’ search interest on COVID-19 vaccine information.

There might be a low supply of evidenced-based COVID-19 vaccine information that allowed the opportunity to generate and spread misinformation [34]. Like other infodemics, the COVID-19 vaccine rumor is highly contagious and can spread exponentially around the world [47]. Development of interventions that target individual, community, cultural and societal-level factors are needed to protect people against rumors and conspiracy theories that flatten the misinformation curve. Online platforms and broadcasting channels, including radio, television, and cable channels, should be targeted to promote risk communication and community engagement. According to Tim Nguyen, the head of high impact events preparedness unit at WHO, “You need to have a certain degree of good information out there to reach populations so that they are inoculated and not susceptible to fake news or disinformation…we believe we need to vaccinate 30% of the population with good information in order to have a certain degree of herd immunity against misinformation” [48]. Websites that provide evidence-based information on COVID-19 vaccines should be developed and disseminated globally as the use of such trusted sources of information have been found effective against misinformation and conspiracy theories [11].

Rumors may also spread offline, for example, word of mouth, and social listening could be utilized to track offline messages. It has been recommended that people should fact check with their family and friends [48]. The WHO recommends a whole-of-society approach to reach diverse communities. Following the bottom-up approach, youth, religious leaders, community stakeholders, faith-based organizations and schools can be engaged to co-design culturally compelling and context-appropriate risk communication and community engagement strategies [48]. International and national health organizations, fact-checking agencies, and infodemic managers can help to identify correct information, and the community ambassadors can diffuse and amplify this information in the community [48].

Moreover, public health agencies should monitor and track the most frequently shared COVID-19 vaccine misinformation on social media [12]. Risk communication targeting disease risks, the role of a vaccine in reducing COVID-19 related morbidity and mortality and known side effects of a vaccine can be posted on social media to improve health literacy among the public.

This study has several limitations. We primarily relied on fact-check and health agency websites, national and international news agencies, and TV channels. All the countries affected by COVID-19 misinformation may not have had all these platforms active during our data collection period. Also, our study may not have detected all misinformation and conspiracy theories circulating online in local native languages. Therefore, the prevalent rumors and conspiracy theories detected through our surveillance could have underestimated the true prevalence. However, we believe our surveillance was timely and covered a reasonable period to enlist vaccine related rumors and conspiracy theories. Secondly, we were unable to track the network of rumors circulating online. For example, many of the rumors we detected were shared multiple times and we did not track further spread of these posts on online platforms. Thirdly, in retrospect, most of the misinformation and conspiracy theories have been debunked by fact-check agencies and national and international health agencies over time. Thus, we do not know if the corrected information changed people’s original perceptions. Finally, as COVID-19 science has been advancing, so information related to vaccine has also been changing, and therefore, some items might be misclassified as facts and vice versa.

In conclusion, our study provided a snapshot of rumor and conspiracy theory patterns circulating online that have the potential to build public distrust in the vaccines. The diverse amount of circulating COVID-19 vaccine misinformation could undermine the universal rollout of the COVID-19 vaccine candidates. We suggested that traditional methods of risk communication and community engagement should be explored to track and fact-check misinformation as ways to immunize people against misinformation and thereby pre-empt potential vaccine program disruptions [49]. Policymakers should consider these findings to devise risk communication and community engagement strategies to address these concerns with evidenced-based information. Additionally, topic modelling, artificial intelligence and machine learning technologies have the potential to track and analyze large media data in real-time; however, these technologies could be expensive for low-and middle-income countries.

Supporting information

S1 Data

(CSV)

Acknowledgments

We are grateful to the governments of Bangladesh, Canada, Sweden, and the United Kingdom for providing core/unrestricted support to the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the home institution of the primary author. We are also grateful to the fact-check agencies and other organizations for making available of the COVID-19 vaccine misinformation and conspiracy theories related data online. We would also like to thank Google for using their public domain website-Google Trends(https://trends.google.com/trends/).

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This work did not receive any funding from a donor.

References

  • 1.Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 Vaccine Hesitancy in the UK: The Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS) II. Psychological Medicine. 2020:1–34. Epub 2020/12/11. 10.1017/S0033291720005188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aylward RB, Heymann DL. Can we capitalize on the virtues of vaccines? Insights from the polio eradication initiative. Am J Public Health. 2005;95(5):773–7. Epub 2005/04/28. 10.2105/AJPH.2004.055897 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med. 2007;4(3):e73. 10.1371/journal.pmed.0040073 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hussain SF, Boyle P, Patel P, Sullivan R. Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue. Global Health. 2016;12(1):63-. 10.1186/s12992-016-0195-3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Health Organization. Immunizing the public against misinformation. Geneva: World Health Organization, 2020 25 August. Report No.
  • 6.Donzelli G, Palomba G, Federigi I, Aquino F, Cioni L, Verani M, et al. Misinformation on vaccination: A quantitative analysis of YouTube videos. Human vaccines & immunotherapeutics. 2018;14(7):1654–9. Epub 2018/03/20. 10.1080/21645515.2018.1454572 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Scheufele DA, Krause NM. Science audiences, misinformation, and fake news. Proceedings of the National Academy of Sciences. 2019;116(16):7662–9. 10.1073/pnas.1805871115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wiyeh AB, Cooper S, Jaca A, Mavundza E, Ndwandwe D, Wiysonge CS. Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa. Vaccine. 2019;37(43):6317–23. Epub 2019/09/16. 10.1016/j.vaccine.2019.09.019 . [DOI] [PubMed] [Google Scholar]
  • 9.Lavorgna L, Ippolito D, Esposito S, Tedeschi G, Bonavita S. A disease in the age of the web: How to help people with Multiple Sclerosis in social media interaction. Mult Scler Relat Disord. 2017;17:238–9. Epub 2017/10/23. 10.1016/j.msard.2017.08.017 . [DOI] [PubMed] [Google Scholar]
  • 10.Islam MS, Sarkar T, Khan SH, Mostofa Kamal AH, Hasan SMM, Kabir A, et al. COVID-19-Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis. Am J Trop Med Hyg. 2020. Epub 2020/08/14. 10.4269/ajtmh.20-0812 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, et al. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis. Mult Scler Relat Disord. 2018;25:175–8. Epub 2018/08/11. 10.1016/j.msard.2018.07.046 . [DOI] [PubMed] [Google Scholar]
  • 12.Waszak PM, Kasprzycka-Waszak W, Kubanek A. The spread of medical fake news in social media—The pilot quantitative study. Health Policy and Technology. 2018;7(2):115–8. 10.1016/j.hlpt.2018.03.002 [DOI] [Google Scholar]
  • 13.Stecula DA, Kuru O, Jamieson KH. How trust in experts and media use affect acceptance of common anti-vaccination claims. The Harvard Kennedy School Misinformation Review. 2020;1(1). Epub January 2020. 10.37016/mr-2020-007 [DOI] [Google Scholar]
  • 14.Durant W. How do we respond to the challenge of vaccine misinformation? Perspectives in public health. 2019;139(6):280–2. 10.1177/1757913919878655 [DOI] [PubMed] [Google Scholar]
  • 15.Fernández-Luque L, Bau T. Health and social media: perfect storm of information. Healthc Inform Res. 2015;21(2):67–73. Epub 04/30. 10.4258/hir.2015.21.2.67 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Roberts M. Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK. BBC. 2020;Sect. Coronavirus pandemic.
  • 17.Larson HJ, Smith DM, Paterson P, Cumming M, Eckersberger E, Freifeld CC, et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. The Lancet Infectious diseases. 2013;13(7):606–13. Epub 2013/05/17. 10.1016/S1473-3099(13)70108-7 . [DOI] [PubMed] [Google Scholar]
  • 18.Bavel JJV, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, et al. Using social and behavioural science to support COVID-19 pandemic response. Nature Human Behaviour. 2020;4(5):460–71. 10.1038/s41562-020-0884-z [DOI] [PubMed] [Google Scholar]
  • 19.Zubiaga A, Liakata M, Procter R, Wong Sak Hoi G, Tolmie P. Analysing How People Orient to and Spread Rumours in Social Media by Looking at Conversational Threads. PloS one. 2016;11(3):e0150989–e. 10.1371/journal.pone.0150989 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wardle C, Singerman E. Too little, too late: social media companies’ failure to tackle vaccine misinformation poses a real threat. BMJ (Clinical research ed). 2021;372:n26. Epub 2021/01/23. 10.1136/bmj.n26 . [DOI] [PubMed] [Google Scholar]
  • 21.Douglas KM, Uscinski JE, Sutton RM, Cichocka A, Nefes T, Ang CS, et al. Understanding Conspiracy Theories. Political Psychology. 2019;40(S1):3–35. 10.1111/pops.12568 [DOI] [Google Scholar]
  • 22.Brennen JS, Simon F, Howard PN, Nielsen RK. Types, sources, and claims of COVID-19 misinformation UK: University of Oxford; 2020 [updated 7 April 2020; cited 2020 29 April]. https://reutersinstitute.politics.ox.ac.uk/types-sources-and-claims-covid-19-misinformation.
  • 23.Zein JG, Whelan G, Erzurum SC. Safety of influenza vaccine during COVID-19. Journal of Clinical and Translational Science. 2020:1–3. Epub 2020/09/17.32257403 [Google Scholar]
  • 24.Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season. Vaccine. 2020;38(2):350–4. Epub 2019/10/10. 10.1016/j.vaccine.2019.10.005 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. Early Release-High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. 2020. [DOI] [PMC free article] [PubMed]
  • 26.Babalola S, Krenn S, Rimal R, Serlemitsos E, Shaivitz M, Shattuck D, et al. KAP COVID Dashboard. USA: Johns Hopkins Center for Communication Programs, Massachusetts Institute of Technology, Global Outbreak Alert and Response Network, Facebook Data for Good, 2020 September. Report No.
  • 27.Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing Vaccination: Putting Psychological Science Into Action. Psychological science in the public interest: a journal of the American Psychological Society. 2017;18(3):149–207. Epub 2018/04/04. 10.1177/1529100618760521 . [DOI] [PubMed] [Google Scholar]
  • 28.Burki T. Vaccine misinformation and social media. The Lancet Digital Health. 2019;1(6). 10.1016/S2589-7500(19)30136-0 [DOI] [Google Scholar]
  • 29.Lewis JR. What Is Driving the Decline in People’s Willingness to Take the COVID-19 Vaccine in the United States? JAMA Health Forum. 2020;1(11):e201393–e. 10.1001/jamahealthforum.2020.1393 [DOI] [PubMed] [Google Scholar]
  • 30.Thigpen CL, Funk C. Most Americans expect a COVID-19 vaccine within a year; 72% say they would get vaccinated. USA: Pew Research Center, 2020.
  • 31.Tyson A, Johnson C, Funk C. U.S. Public Now Divided Over Whether To Get COVID-19 Vaccine: Concerns about the safety and effectiveness of possible vaccine, pace of approval process. USA: Pew Research Center Science and Society, 2020.
  • 32.Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Global Health. 2020;5(10):e004206. 10.1136/bmjgh-2020-004206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. The Lancet Infectious diseases. 2020:S1473-3099(20)30724-6. 10.1016/S1473-3099(20)30724-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Smith R, Cubbon S, Wardle C. Under the surface: Covid-19 vaccine narratives, misinformation & data deficits on social media. USA: First Draft, 2020.
  • 35.Group C. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet Infectious diseases. 2020;20(7):769–70. Epub 2020/05/24. 10.1016/S1473-3099(20)30426-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kennedy J. Populist politics and vaccine hesitancy in Western Europe: an analysis of national-level data. European Journal of Public Health. 2019;29(3):512–6. 10.1093/eurpub/ckz004 [DOI] [PubMed] [Google Scholar]
  • 37.Galvão J. COVID-19: the deadly threat of misinformation. The Lancet Infectious diseases. 2020:S1473-3099(20)30721-0. 10.1016/S1473-3099(20)30721-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bhattacharjee S, Dotto C. First Draft case study: Understanding the impact of polio vaccine disinformation in Pakistan. United States: First Draft, 2020.
  • 39.The Daily Star. Covid-19 will leave the country on its own: health minister. The Daily Star. 2020 August 15.
  • 40.Richtel M. W.H.O. Fights a Pandemic Besides Coronavirus: An ‘Infodemic’. The New York Times. 2020 6 February 2020;Sect. The Coronavirus Outbreak.
  • 41.Arab Writers: The Coronavirus Is Part Of Biological Warfare Waged By The U.S. Against China [Internet]. Meddle East Media Research Institute TV. 2020 [cited 30 March 2020]. https://www.memri.org/reports/arab-writers-coronavirus-part-biological-warfare-waged-us-against-china.
  • 42.Thorburn Bird S, Bogart LM. Birth control conspiracy beliefs, perceived discrimination, and contraception among African Americans: An exploratory study. Journal of Health Psychology. 2003;8(2):263–76. 10.1177/1359105303008002669 [DOI] [PubMed] [Google Scholar]
  • 43.ABC News. There’s no evidence the flu shot increases your chances of getting COVID-19. ABC News. 2020 16 May;Sect. FAck Check.
  • 44.Jamal U. Why is Indonesia concerned about a halal COVID-19 vaccine? ASEAN Today. 2020 28 October;Sect. COVID-19.
  • 45.Rochmyaningsih D. Indonesian fatwa causes immunization rates to drop. Science. 2018;362(6415):628–9. 10.1126/science.362.6415.628 [DOI] [PubMed] [Google Scholar]
  • 46.Pelčić G, Karačić S, Mikirtichan GL, Kubar OI, Leavitt FJ, Cheng-Tek Tai M, et al. Religious exception for vaccination or religious excuses for avoiding vaccination. Croat Med J. 2016;57(5):516–21. 10.3325/cmj.2016.57.516 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.World Health Organization. Immunizing the public against misinformation Geneva, Switzerland: World Health Organization; 2020 [updated 25 August 2020; cited 2020 August 27]. https://www.who.int/news-room/feature-stories/detail/immunizing-the-public-against-misinformation.
  • 48.World Health Organization. Immunizing the public against misinformation Geneva: World Health Organization; 2020 [updated 25 August 2020; cited 2020 23 October]. https://www.who.int/news-room/feature-stories/detail/immunizing-the-public-against-misinformation.
  • 49.Bontcheva K, Posetti J, Teyssou D, Meyer T, Gregory S, Hanot C, et al. Balancing Act: Countering Digital Disinformation While Respecting Freedom of Expression. Geneva, Switzerland: United Nations Educational, Scientific and Cultural Organization, 2020.

Decision Letter 0

Luigi Lavorgna

15 Apr 2021

PONE-D-21-06301

COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence

PLOS ONE

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Luigi Lavorgna

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

  1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

  1. Thank you for stating the following in the Competing Interests section:

The authors have declared that no competing interests exist.

We note that one or more of the authors are employed by a commercial company: Independent Researcher, Sydney, Australia

2a,  Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. 

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

  1. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

3a, You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

3b, If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: interesting and large integrated report from social media scenario regarding COVID vaccination. Risk of misinformation may lead to important delay in institutional strategy to limit COVID pandemic. I suggest to implement in the discussion the impact of social media influence on population suffering from chronicities focused on coping and fake news and how patients have increasingly been searching for health information on the Internet (see Lavorgna L et al Interact J Med Res. 2017, Lavorgna L et al Mult Scler Relat Disord 2018 ). Figure 3 could be corrected (twiter), but I suggest switching to a better way to show the data (numbers alone poor appealing)

Reviewer #2: The manuscript by Md Saiful Islam et al examine COVID-19 vaccine rumors circulating on online platforms and review interventions to manage misinformation and increase vaccine acceptance. There is emerging interest on the role of internet and social media in influencing the effectiveness of programs, campaigns and initiatives aimed at citizens' health, awareness and well-being; therefore, the article is highly topical. It is well-structured and well written; methods are sound. I only have some minor suggestions to the authors.

- Nowadays, social media have become part of people's daily activities. They facilitate the exchange of information and allow people to share interests, information and personal experiences, overcoming daily limitations of space and time. Therefore, I suggest introducing the role of internet and social media as source of information for patients to highlight the relevance of the paper. (Suggested references: Moccia M, Brigo F, Tedeschi G, Bonavita S, Lavorgna L. Neurology and the Internet: a review. Neurol Sci. 2018 Jun;39(6):981-987. Doi: 10.1007/s10072-018-3339-9. Epub 2018 Mar 28. PMID: 29594831).

- I would also suggest adding in discussion further examples concerning possible solutions to the spread of misinformation through social media. (Suggested references: Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, Buonanno D, Esposito S, Clerico M, Cenci C, Trojsi F, Lanzillo R, Rosa L, Morra VB, Ippolito D, Maniscalco G, Bisecco A, Tedeschi G, Bonavita S. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis. Mult Scler Relat Disord. 2018; Waszak PM, Kasprzycka-Waszak W, Kubanek A. The spread of medical fake news in social media – The pilot quantitative study. Health Policy and Technology. 2018 Jun;7(2):115–118. doi: 10.1016/j.hlpt.2018.03.002.)

- Page 19: “COVDI-19”: amend

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 May 12;16(5):e0251605. doi: 10.1371/journal.pone.0251605.r002

Author response to Decision Letter 0


27 Apr 2021

PONE-D-21-06301

26-Apr-2021

To

Luigi Lavorgna

Academic Editor

PLOS ONE

We are thankful to the editor and the reviewers for their thorough reviews of the manuscript and for allowing us to respond to the comments. Based on the feedback, we revised the manuscript. The manuscript has also been reviewed by a professional English writing consultant for clarity and flow. The following is an itemized list of our specific responses to the editor and each reviewer's comments. We have also highlighted where the changes have been made in the revision. Now, we believe the manuscript is updated, more precise, clear, and informative.

Comments: Journal Requirements

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: Thank you. Based on your suggestion, we reviewed the PLOS ONE's style requirements and revised the authors' affiliation and body of the manuscript.

Comments: Thank you for stating the following in the Competing Interests section:

The authors have declared that no competing interests exist.

We note that one or more of the authors are employed by a commercial company: Independent Researcher, Sydney, Australia

Response: The commercial affiliation did not play a role in our study, and this does not alter our adherence to PLOS ONE policies of sharing data and materials. Now, we have added this statement in the cover letter.

Comments: 2a, Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

"The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials." (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Response: As suggested, we updated the Competing Interest Statements and funding statement in the cover letter as “Associate Professor Holly Seale has previously received funding from drug companies for investigator-driven research and consulting fees to present at conferences/workshops and develop resources (Seqirus, GSK and Sanofi Pasteur). She has also participated in an advisory board meeting for Sanofi Pasteur.

This work has been a voluntary contribution from all authors. The commercial affiliation of the authors did not play a role in our study, and this does not alter our adherence to PLOS ONE policies of sharing data and materials.

The funder provided support in the form of salaries for authors [MSI, AMK, AK, DLS, SHK, SMMH, TS, SS, SD, TR, MGDH, AAC, NH, HS], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section”.

Comment:

1. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

3a, You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

"I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form."

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: "Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year]."

3b, If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder's requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Response: Figure 1 is original; it has not been copied from any published literature. Based on our data, we created figure 1 using R-statistical software. Therefore, we do not require any copyright permission.

Comments: 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the retracted status in the References list and include a citation and full reference for the retraction notice.

Response: Thank you. We have double-checked the references and did not find any reference that has been retracted.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1:

Comments: Interesting and large integrated report from social media scenario regarding COVID vaccination. Risk of misinformation may lead to important delay in institutional strategy to limit COVID pandemic. I suggest to implement in the discussion the impact of social media influence on population suffering from chronicities focused on coping and fake news and how patients have increasingly been searching for health information on the Internet (see Lavorgna L et al Interact J Med Res. 2017, Lavorgna L et al Mult Scler Relat Disord 2018 ).

Response: Thank you for the compliment. We have reviewed the articles recommended and updated the introduction and the discussion section. On page 5 in the Introduction, we have added the following lines, "The social media platform has become a common source for health information. During a pandemic, people may use social media to improve their knowledge about the disease, transmission, and prevention mechanisms[1, 2]. Health information circulating on online platforms are often amplified by misinformation, conspiracy theories, and myths that are not always based on scientific evidence [3]. Health information-seeking behavior on online platforms puts users at risk of being exposed to misinformation and conspiracy theories that could potentially threaten public health[4]. See the manuscript with track changes.

Comments: Figure 3 could be corrected (twiter), but I suggest switching to a better way to show the data (numbers alone poor appealing)

Response: Thank you for noticing this typo. We have corrected it. We think, to present the interaction between groups, Venn diagram is a useful tool. We now incorporated the percentages along with the numbers.

Reviewer #2:

Comments: The manuscript by Md Saiful Islam et al examine COVID-19 vaccine rumors circulating on online platforms and review interventions to manage misinformation and increase vaccine acceptance. There is emerging interest on the role of internet and social media in influencing the effectiveness of programs, campaigns and initiatives aimed at citizens' health, awareness and well-being; therefore, the article is highly topical. It is well-structured and well written; methods are sound. I only have some minor suggestions to the authors.

Response: Thank you for the appreciation.

Comments: Nowadays, social media have become part of people's daily activities. They facilitate the exchange of information and allow people to share interests, information and personal experiences, overcoming daily limitations of space and time. Therefore, I suggest introducing the role of internet and social media as source of information for patients to highlight the relevance of the paper. (Suggested references: Moccia M, Brigo F, Tedeschi G, Bonavita S, Lavorgna L. Neurology and the Internet: a review. Neurol Sci. 2018 Jun;39(6):981-987. Doi: 10.1007/s10072-018-3339-9. Epub 2018 Mar 28. PMID: 29594831).

Response: Thank you. Based on your recommendations, we have now added, ""The social media platform has become a common source for health information. During a pandemic, people may use social media to improve their knowledge about the disease, transmission, and prevention mechanisms[1, 2]. Health information circulating on online platforms are often amplified by misinformation, conspiracy theories, and myths that are not always based on scientific evidence [3, 4]. Health information-seeking behaviour online puts users at risk of accessing misinformation and conspiracy theories that could potentially threaten public health[4]." on page 5.

Comments: I would also suggest adding in discussion further examples concerning possible solutions to the spread of misinformation through social media. (Suggested references: Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, Buonanno D, Esposito S, Clerico M, Cenci C, Trojsi F, Lanzillo R, Rosa L, Morra VB, Ippolito D, Maniscalco G, Bisecco A, Tedeschi G, Bonavita S. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis. Mult Scler Relat Disord. 2018; Waszak PM, Kasprzycka-Waszak W, Kubanek A. The spread of medical fake news in social media – The pilot quantitative study. Health Policy and Technology. 2018 Jun;7(2):115–118. doi: 10.1016/j.hlpt.2018.03.002.)

Response: On page 23, we added, "Websites that provide evidence-based information on COVID-19 vaccines should be developed and disseminated globally as the use of such trusted sources of information were found effective against misinformation and conspiracy theories [3].

On pages 23-24, we added," Moreover, public health agencies should monitor and track the most frequently shared COVID-19 vaccine misinformation on social media [4]. Risk communication targeting disease risks, the role of a vaccine in reducing COVID-19 related morbidity and mortality, and known side effects of a vaccine can be posted on social media to improve health literacy among the public.

Comments: Page 19: "COVDI-19": amend

Response: Thank you for notifying this typo. We have now corrected this to “COVID-19”on page 24.

1. Lavorgna L, Ippolito D, Esposito S, Tedeschi G, Bonavita S. A disease in the age of the web: How to help people with Multiple Sclerosis in social media interaction. Mult Scler Relat Disord. 2017;17:238-9. Epub 2017/10/23. doi: 10.1016/j.msard.2017.08.017. PubMed PMID: 29055466.

2. Islam MS, Sarkar T, Khan SH, Mostofa Kamal AH, Hasan SMM, Kabir A, et al. COVID-19-Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis. Am J Trop Med Hyg. 2020. Epub 2020/08/14. doi: 10.4269/ajtmh.20-0812. PubMed PMID: 32783794.

3. Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, et al. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis. Mult Scler Relat Disord. 2018;25:175-8. Epub 2018/08/11. doi: 10.1016/j.msard.2018.07.046. PubMed PMID: 30096683.

4. Waszak PM, Kasprzycka-Waszak W, Kubanek A. The spread of medical fake news in social media – The pilot quantitative study. Health Policy and Technology. 2018;7(2):115-8. doi: https://doi.org/10.1016/j.hlpt.2018.03.002.

Attachment

Submitted filename: 2021 Apr 21_Response to reviewers comments.docx

Decision Letter 1

Luigi Lavorgna

29 Apr 2021

COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence

PONE-D-21-06301R1

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Luigi Lavorgna

Academic Editor

PLOS ONE

Acceptance letter

Luigi Lavorgna

5 May 2021

PONE-D-21-06301R1

COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence.

Dear Dr. Islam:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Luigi Lavorgna

Academic Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES